Surgery – Truss – Perineal
Patent
1979-10-31
1982-07-06
Recla, Henry J.
Surgery
Truss
Perineal
128804, A61B 1900
Patent
active
043377602
ABSTRACT:
Hyperacidified tumors having high .beta.-glucuronidase activity can be treated with glucuronides with aglycones toxic to the tumor cells with great safety toward the rest of the body by first administering an alkalinizing agent in an amount sufficient to maintain the pH level of non-tumor tissues at approximately 7.4 during the glucuronide treatment. This will cause inactivation of .beta.-glucuronidase activity in the rest of the body. When nitrile-containing aglycones are used sodium thiosulfate is also administered to avoid cyanide poisoning. Novel glucuronides are disclosed the aglycones of which exert a higher toxic effect in an acid environment or are water-soluble only in an alkaline environment. Such compounds have particular utility with the above process. By substituting radioisotopes into the aglycone, diagnosis and in situ radiation therapy may be accomplished. Bacterial cells having .beta.-glucuronidase activity may also be diagnosed and treated in accordance with the present invention. A urine test is disclosed to determine the amount of free glucuronic acid in the urine which is an indication of the presence of a tumor in the body having high .beta.-glucuronidase activity. Novel methods of synthesizing the glucuronide used in the present invention are also disclosed.
REFERENCES:
patent: 4106488 (1978-08-01), Gordon
patent: 4181132 (1980-01-01), Parks
"Laetrille", Merck Index 9th Ed.
Recla Henry J.
Rubin David
Schwartz Irwin Steven
Schwimmer Adolf
Wallen T. J.
LandOfFree
Method for the treatment of tumors with .beta.-glucuronidase act does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of tumors with .beta.-glucuronidase act, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of tumors with .beta.-glucuronidase act will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2164322